PINK
SNWV

SANUWAVE Health Inc

Medical Devices
Healthcare

Prices are adjusted according to historical splits.

SANUWAVE Health Inc Stock Price

Vitals

Today's Low:
$0.0193
Today's High:
$0.0206
Open Price:
$0.0206
52W Low:
$0.0098
52W High:
$0.075
Prev. Close:
$0.0199
Volume:
56611

Company Statistics

Market Cap.:
$19.80 million
Book Value:
-0.108
Revenue TTM:
$18.12 million
Operating Margin TTM:
-27.57%
Gross Profit TTM:
$8.02 million
Profit Margin:
-150.03%
Return on Assets TTM:
-16.51%
Return on Equity TTM:
0%

Company Profile

SANUWAVE Health Inc had its IPO on under the ticker symbol SNWV.

The company operates in the Healthcare sector and Medical Devices industry. SANUWAVE Health Inc has a staff strength of 38 employees.

Stock update

Shares of SANUWAVE Health Inc opened at $0.02 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.02 - $0.02, and closed at $0.02.

This is a -3.02% slip from the previous day's closing price.

A total volume of 56,611 shares were traded at the close of the day’s session.

In the last one week, shares of SANUWAVE Health Inc have slipped by -3.02%.

SANUWAVE Health Inc's Key Ratios

SANUWAVE Health Inc has a market cap of $19.80 million, indicating a price to book ratio of 0 and a price to sales ratio of 1.0619.

In the last 12-months SANUWAVE Health Inc’s revenue was $18.12 million with a gross profit of $8.02 million and an EBITDA of $-3973000. The EBITDA ratio measures SANUWAVE Health Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, SANUWAVE Health Inc’s operating margin was -27.57% while its return on assets stood at -16.51% with a return of equity of 0%.

In Q2, SANUWAVE Health Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 20.4%.

SANUWAVE Health Inc’s PE and PEG Ratio

Forward PE
0
Trailing PE
0
PEG
0

Its diluted EPS in the last 12-months stands at $-0.05 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into SANUWAVE Health Inc’s profitability.

SANUWAVE Health Inc stock is trading at a EV to sales ratio of 3.1811 and a EV to EBITDA ratio of 28.7374. Its price to sales ratio in the trailing 12-months stood at 1.0619.

SANUWAVE Health Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$19.20 million
Total Liabilities
$79.28 million
Operating Cash Flow
$0
Capital Expenditure
$151000
Dividend Payout Ratio
0%

SANUWAVE Health Inc ended 2024 with $19.20 million in total assets and $0 in total liabilities. Its intangible assets were valued at $19.20 million while shareholder equity stood at $-60838000.00.

SANUWAVE Health Inc ended 2024 with $0 in deferred long-term liabilities, $79.28 million in other current liabilities, 562000.00 in common stock, $-214584000.00 in retained earnings and $7.26 million in goodwill. Its cash balance stood at $332000.00 and cash and short-term investments were $332000.00. The company’s total short-term debt was $44,870,000 while long-term debt stood at $0.

SANUWAVE Health Inc’s total current assets stands at $6.10 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $2.82 million compared to accounts payable of $4.86 million and inventory worth $900000.00.

In 2024, SANUWAVE Health Inc's operating cash flow was $0 while its capital expenditure stood at $151000.

Comparatively, SANUWAVE Health Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$0.02
52-Week High
$0.075
52-Week Low
$0.0098
Analyst Target Price
$

SANUWAVE Health Inc stock is currently trading at $0.02 per share. It touched a 52-week high of $0.075 and a 52-week low of $0.075. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $0.02 and 200-day moving average was $0.03 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 3477.4% of the company’s stock are held by insiders while 573.1% are held by institutions.

Frequently Asked Questions About SANUWAVE Health Inc

The stock symbol (also called stock or share ticker) of SANUWAVE Health Inc is SNWV

The IPO of SANUWAVE Health Inc took place on

Similar Industry Stocks (Medical Devices)

Last Price
Chg
Chg%
$1720
-35.3
-2.01%
$791.2
-59.9
-7.04%
$0.85
0
0%
Savills plc (SVLPF)
$10.71
0
0%
ACC LTD. (ACC)
$2009.3
-41.7
-2.03%
$7.58
0.18
+2.43%
nLIGHT Inc (LASR)
$10.2
-0.39
-3.68%
$3477.2
-199.65
-5.43%
$59.29
-0.34
-0.57%
$1.64
-0.06
-3.53%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company’s pulsed acoustic cellular expression systems, including dermaPACE system for treating diabetic foot ulcers and other chronic wounds; orthoPACE system for treating tendinopathies and acute and nonunion fractures; and Profile is used to provide therapeutic treatment of musculoskeletal conditions. Its portfolio of wound treatment solutions provides patients with a noninvasive technology that boosts the body’s normal healing and tissue regeneration processes. In addition, the company offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds. SANUWAVE Health, Inc. was founded in 2004 and is headquartered in Eden Prairie, Minnesota.

Address

3360 Martin Farm Road, Suwanee, GA, United States, 30024